Published in Hoppe Seylers Z Physiol Chem on October 01, 1978
Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity. Biochem J (1982) 1.04
Glycosphingolipids-sweets for botulinum neurotoxin. Glycoconj J (2004) 0.83
Oligosaccharide-derivatized dendrimers: defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconj J (1997) 0.80
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology (2010) 3.58
Faithful cell-cycle regulation of a recombinant mouse histone H4 gene is controlled by sequences in the 3'-terminal part of the gene. Proc Natl Acad Sci U S A (1985) 3.03
Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest (1990) 2.86
In vitro studies of cell-bound immunity; cloning assay of the cytotoxic action of sensitized lymphoid cells on allogeneic target cells. Immunology (1966) 2.27
Diameter of the cell-to-cell junctional membrane channels as probed with neutral molecules. Science (1981) 1.76
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation (1992) 1.71
STED nanoscopy reveals molecular details of cholesterol- and cytoskeleton-modulated lipid interactions in living cells. Biophys J (2011) 1.69
The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging (2010) 1.68
Structure of tetanus toxin. II. Toxin binding to ganglioside. J Biol Chem (1977) 1.63
A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med (1996) 1.60
Association between rheology and components of lipoproteins in human blood. Results from the MONICA project. Circulation (1992) 1.54
Effects of the Tibetan herbal preparation PADMA 28 on blood lipids and lipid oxidisability in subjects with mild hypercholesterolaemia. Vasa (2005) 1.49
Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? Nephrol Dial Transplant (1995) 1.45
Direct measurement of spin-lattice relaxation times of phosphorus metabolites in human myocardium. Magn Reson Med (1992) 1.42
[Clinical aspects and therapy of amniotic fluid embolism. Illustration based on a case report]. Z Geburtshilfe Neonatol (1997) 1.39
Targeting of protein ERGIC-53 to the ER/ERGIC/cis-Golgi recycling pathway. J Cell Biol (1995) 1.37
Gangliosides of extraneural organs. Hoppe Seylers Z Physiol Chem (1973) 1.36
Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem (1999) 1.29
A simple and novel method for tritium labeling of gangliosides and other sphingolipids. Biochim Biophys Acta (1978) 1.27
Lysogangliosides: synthesis and use in preparing labeled gangliosides. Methods Enzymol (1987) 1.24
Studies on the division cycle of mammalian cells. 3. Preparation of synchronously dividing cell populations by isotonic sucrose gradient centrifugation. Exp Cell Res (1970) 1.21
The requirement of mammalian cell cultures for serum proteins. Growth-promoting activity of pepsin-digested serum albumin in different media. Biochim Biophys Acta (1967) 1.18
Carbohydrate components of extraneuronal gangliosides from bovine and human spleen, and bovine kidney. Eur J Biochem (1970) 1.16
Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects. Eur J Biochem (1985) 1.16
Incorporation of ganglioside analogues into fibroblast cell membranes. A spin-label study. Biochemistry (1983) 1.15
Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection. Transpl Infect Dis (2007) 1.12
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord (2006) 1.12
Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis (1990) 1.11
A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. Cancer Res (1986) 1.09
The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A. J Biol Chem (1991) 1.08
Bilateral emphysematous pyelonephritis caused by Candida infection. Am J Kidney Dis (1999) 1.06
Importance of the Gastroscope in the Diagnosis of Gastric Diseases in the Army. Br Med J (1940) 1.06
Micellar properties of glycosphingolipids in aqueous media. J Lipid Res (1984) 1.05
Formation of mast cell granules in cell cycle mutants of an undifferentiated mastocytoma line: evidence for two different states of reversible proliferative quiescence. J Cell Biol (1983) 1.05
A comparison of complement-fixation and fluorescent antibody methods in a longitudinal study of simian malaria infection. Bull World Health Organ (1967) 1.04
Over-expression of a functionally active human GM2-activator protein in Escherichia coli. Biochem J (1993) 1.04
Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophys Res Commun (1992) 1.03
Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Heart Circ Physiol (2000) 1.01
Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells. J Biol Chem (1998) 1.01
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood (1991) 0.99
Dominant versus recessive behavior of a cold- and a heat-sensitive mammalian cell cycle variant in heterokaryons. Somatic Cell Genet (1981) 0.99
Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report. J Clin Microbiol (1998) 0.98
Glycosphingolipid specificity of the human sulfatide activator protein. Eur J Biochem (1991) 0.98
Lipid-protein interactions and effect of local anesthetics in acetylcholine receptor-rich membranes from Torpedo marmorata electric organ. Biochemistry (2003) 0.97
Cholera toxin induced redistribution of sialoglycolipid receptor at the lymphocyte membrane. FEBS Lett (1976) 0.97
Demonstration of protease-like activity in human serum low density lipoprotein. FEBS Lett (1974) 0.95
Both GA2, GM2, and GD2 synthases and GM1b, GD1a, and GT1b synthases are single enzymes in Golgi vesicles from rat liver. Proc Natl Acad Sci U S A (1988) 0.95
Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments. Exp Cell Res (1998) 0.95
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer (2001) 0.95
Characterization of the cellular binding of exogenous gangliosides. Eur J Biochem (1977) 0.94
Intracellular distribution of a biotin-labeled ganglioside, GM1, by immunoelectron microscopy after endocytosis in fibroblasts. J Histochem Cytochem (1999) 0.94
Glycosphingolipid composition of human semen. Arch Biochem Biophys (1987) 0.93
Kinetic cell-cycle analysis of a cultured mammalian cell population. Biophys J (1974) 0.93
Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism. Eur J Cell Biol (1995) 0.93
Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain. Biol Chem Hoppe Seyler (1986) 0.93
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood (1989) 0.92
Studies of the subunit structure of choleragen. Eur J Biochem (1975) 0.92
Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route? Agents Actions (1987) 0.92
On the structure of two new gangliosides from beef brain. J Neurochem (1976) 0.92
Experimentation with smokeless tobacco and cigarettes by children and adolescents: relationship to beliefs, peer use, and parental use. Am J Public Health (1987) 0.92
Interaction of ganglioside G Gtet1 and its derivatives with choleragen. Eur J Biochem (1974) 0.91
Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant (1999) 0.91
Comparative study of procedures for isolation and cultivation of Legionella pneumophila from tap water in hospitals. J Clin Microbiol (1993) 0.91
The use of reductaminated sugars for the preparation of oligosaccharide conjugates, I. Synthetic glycolipids containing glycosphingolipid-derived oligosaccharides. Hoppe Seylers Z Physiol Chem (1974) 0.91
Sialic-acid content of low-density lipoproteins controls their binding and uptake by cultured cells. Eur J Biochem (1979) 0.91
Exogenous glycosphingolipids suppress growth rate of transformed and untransformed 3T3 mouse cells. Exp Cell Res (1975) 0.91
Increased sensitivity of mammalian cell cultures to radiomimetic alkylating agents following incorporation of 5-bromodeoxyuridine into cellular DNA. Biochem Pharmacol (1966) 0.90
Direct evidence by carbon-13 NMR spectroscopy for the erythro configuration of the sphingoid moiety in Gaucher cerebroside and other natural sphingolipids. Eur J Biochem (1985) 0.90
Glycosphingolipids of human gliomas. Cancer Res (1990) 0.90
A dual role for COOH-terminal lysine residues in pre-Golgi retention and endocytosis of ERGIC-53. J Biol Chem (1994) 0.90
The subcellular localization of gangliosides in the brain. J Neurochem (1967) 0.89
Minor effects of bulk viscosity on lipid translational diffusion measured by the excimer formation technique. Eur Biophys J (1988) 0.89
Aggregate formation of gangliosides at low concentrations in aqueous media. Hoppe Seylers Z Physiol Chem (1980) 0.88
Studies of the ligand binding to cholera toxin, II. The hydrophilic moiety of sialoglycolipids. Hoppe Seylers Z Physiol Chem (1977) 0.88
Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells. Eur J Immunol (1992) 0.87
Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol (1999) 0.87
Kinetic aspects of lymphocyte recirculation. Int Arch Allergy Appl Immunol (1971) 0.87
Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol (1985) (1991) 0.87
Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol (1993) 0.87
Thin layer chromatography overlay technique in the analysis of the binding of the solubilized protoxin of Bacillus thuringiensis var. kurstaki to an insect glycosphingolipid of known structure. Biomed Chromatogr (1986) 0.87
"Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis. Ann Rheum Dis (2005) 0.86
Studies on the Lp(a)-lipoprotein of human serum. IV. The disaggregation of the Lp(a)-lipoprotein. Humangenetik (1972) 0.86
Green urine after motorcycle accident. Nephrol Dial Transplant (2000) 0.86
Studies on the division cycle of mammalian cells. V. Modifications of time parameters by different steady-state culture conditions. J Cell Biol (1971) 0.86
Glycosphingolipids in insects. Chemical structures of ceramide tetra-, penta-, hexa-, and heptasaccharides from Calliphora vicina pupae (Insecta: Diptera). J Biol Chem (1985) 0.85
Synchrony of long duration in suspension cultures of mammalian cells. Nat New Biol (1971) 0.85
Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases. FEBS Lett (1976) 0.85
Characterization of anti-ganglioside antibodies present in normal human plasma. J Neuroimmunol (1994) 0.85